A Combination of PD-1 and TIGIT Checkpoint Blockade Elicits a Strong Antitumor Response in the Patient and Mouse Pleural Mesothelioma Model

被引：0
|
作者：
Shi, H. [1 ]
Johnson, B. [1 ]
Yu, T. -K. [1 ]
Zhuang, L. [1 ]
Selvamani, S. P. [1 ]
Lee, K. [2 ]
Klebe, S. [3 ]
Chen, K. [4 ]
Clark, G. [4 ]
Kao, S. [1 ]
Silveira, P. [4 ]
Cheng, Y. Y. [5 ]
机构：
[1] Asbestos Dis Res Inst, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW, Australia
[3] Flinders Hlth & Med Res Inst, Adelaide, SA, Australia
[4] Anzac Res Inst, Sydney, NSW, Australia
[5] Inst Biomed Mat & Devices IBMD, Sydney, NSW, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
pleural mesothelioma; immune checkpoint inhibitor; mouse model;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.21-02
引用
收藏
页码：S388 / S388
页数：1
相关论文
共 50 条
  • [21] Fulminant Immune-mediated Myocarditis in a Metastatic Cancer Patient on Combination Therapy of TIGIT and PD-1 Immune Checkpoint Inhibitors
    Fallahi, Sara
    Kraus, Samuel
    Abdelaziz, Ahmed
    Parks, Bruce
    LABORATORY INVESTIGATION, 2024, 104 (03) : S12 - S13
  • [22] Pegylated Arginine Deiminase Potentiates PD-1/PD-L1 Immune Checkpoint Blockade in Malignant Mesothelioma
    Szlosarek, P.
    Khadeir, R.
    Sheaff, M.
    Locke, M.
    Lau, K.
    Wu, B.
    Bomalaski, J.
    Martin, S.
    Quezada, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1884 - S1884
  • [23] Response: Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
    Lin, Yan
    Sandusky-Beltran, Leslie A.
    Gamallo-Lana, Begona
    Mar, Adam
    Sigurdsson, Einar M.
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [24] PD-1/PD-L1 Checkpoint Inhibitor Immunotherapy for Malignant Pleural Mesothelioma: Case Series and Literature Review
    Zhou, Maggie
    Joshi, Nitin
    Raj, Kavitha P.
    Wakelee, Heather
    Neal, Joel W.
    CLINICAL LUNG CANCER, 2021, 22 (03) : E329 - E335
  • [25] Prognostic Signature of Response to PD-1 Immune Checkpoint Blockade in Lung Cancer
    Ding, Juan
    Sun, Tingting
    Yao, Juan
    Zheng, Ni
    Lu, Rong
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (02): : 617 - 628
  • [26] COMBINATION OF VEGF-A AND PD-1 BLOCKADE MAY ENHANCE ANTITUMOR EFFICACY IN GBM
    Long, Yu
    Yang, Changlin
    Jin, Linchun
    Ge, Haitao
    Bao, Hongbo
    Flores, Catherine
    Lin, Zhiguo
    Mitchell, Duane
    Huang, Jianping
    NEURO-ONCOLOGY, 2016, 18 : 91 - 91
  • [27] Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model
    Lin, Yan
    Rajamohamedsait, Hameetha B.
    Sandusky-Beltran, Leslie A.
    Gamallo-Lana, Begona
    Mar, Adam
    Sigurdsson, Einar M.
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 11
  • [28] COBLOCKADE OF TIGIT AND PD-1 OPTIMIZES ANTITUMOR CD8+ T-CELL RESPONSE
    不详
    CANCER DISCOVERY, 2022, 12 (05) : 1182 - 1182
  • [29] TIGIT blockade combined with local radiotherapy and PD-1 blockade in a murine triple-negative breast cancer model
    Kim, Seongmin
    Jeon, Seung Hyuck
    Kim, In Ah
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors
    Thuru, Xavier
    Magnez, Romain
    El-Bouazzati, Hassiba
    Vergoten, Gerard
    Quesnel, Bruno
    Bailly, Christian
    CANCERS, 2022, 14 (14)
12345